By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



8 Hillside Avenue
Suite 207
Montclair  New Jersey  07042  U.S.A.
Phone: 832-758-7488 Fax: n/a



Company News
MetaStat Welcomes Renato T. Skerlj, Ph.D., Accomplished Drug Developer To Its Scientific And Clinical Advisory Board 8/3/2017 7:07:52 AM
MetaStat Release: Study Demonstrates Paclitaxel Treatment Promotes Breast Cancer Dissemination And Metastasis In A Mena-Dependent Manner 7/19/2017 7:34:49 AM
MetaStat Closes First Round Of A $7 Million Private Placement 6/27/2017 10:01:54 AM
MetaStat Announces Completion Of Second Milestone Of Its Pilot Research Project With Celgene (CELG) 6/19/2017 8:48:16 AM
MetaStat Expands Therapeutic And Companion Diagnostic Intellectual Property Portfolio 5/23/2017 9:28:38 AM
MetaStat Elevates Jerome B. Zeldis, M.D., Ph.D. To Chairman Of The Board And Appoints Douglas A. Hamilton, Metastat’s President And CEO To Its Board Of Directors 5/8/2017 10:25:29 AM
MetaStat Release: Mena Expression Is Associated With Paclitaxel-Mediated Increase In Cancer Cell Dissemination 4/6/2017 7:53:11 AM
MetaStat Receives Additional State Clinical Laboratory Licenses 12/19/2016 9:26:55 AM
MetaStat Presents Positive Data From Two Clinical Studies Of MetaSite Breast At 2016 San Antonio Breast Cancer Symposium 12/13/2016 11:05:35 AM
MetaStat Closes Private Placement Of Common Stock And Warrants 10/27/2016 10:44:43 AM